Cargando…

Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience

PURPOSE: Our purpose was to assess the safety and efficacy of intensity modulated proton therapy (IMPT) for the treatment of hepatocellular carcinoma (HCC). METHODS AND MATERIALS: A retrospective review was conducted on all patients who were treated with IMPT for HCC with curative intent from June 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhangoo, Ronik S., Mullikin, Trey C., Ashman, Jonathan B., Cheng, Tiffany W., Golafshar, Michael A., DeWees, Todd A., Johnson, Jedediah E., Shiraishi, Satomi, Liu, Wei, Hu, Yanle, Merrell, Kenneth W., Haddock, Michael G., Krishnan, Sunil, Rule, William G., Sio, Terence T., Hallemeier, Christopher L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361033/ https://www.ncbi.nlm.nih.gov/pubmed/34409199 http://dx.doi.org/10.1016/j.adro.2021.100675

Ejemplares similares

Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience
por: Bhangoo, Ronik S., et al.
Publicado: (2020)

Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small‐spot intensity‐modulated proton versus volumetric‐modulated arc therapies
por: Liu, Chenbin, et al.
Publicado: (2019)

Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the Anus()()
por: Mohiuddin, Jahan J., et al.
Publicado: (2021)

Clinical Implementation of Preoperative Short-Course Pencil Beam Scanning Proton Therapy for Patients With Rectal Cancer
por: Jeans, Elizabeth B., et al.
Publicado: (2020)

Beam angle comparison for distal esophageal carcinoma patients treated with intensity‐modulated proton therapy
por: Feng, Hongying, et al.
Publicado: (2020)

Evaluation of Pretreatment Magnetic Resonance Elastography for the Prediction of Radiation-Induced Liver Disease
por: Mullikin, Trey C., et al.
Publicado: (2021)

Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience
por: Laughlin, Brady S., et al.
Publicado: (2022)

Quantification of Potential Inequities in Breast Cancer Incidence in New Mexico Through Bayesian Disease Mapping
por: Zahrieh, David, et al.
Publicado: (2021)

Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer
por: Anderson, Justin D., et al.
Publicado: (2022)

Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy
por: Laughlin, Brady S., et al.
Publicado: (2022)

Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry
por: Thorpe, C. S., et al.
Publicado: (2022)

Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non–small cell lung cancer
por: Breen, William G., et al.
Publicado: (2016)

Early Experience Using Proton Beam Therapy for Extremity Soft Tissue Sarcoma: A Multicenter Study
por: Laughlin, Brady S., et al.
Publicado: (2022)

Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery
por: Thorpe, Cameron S., et al.
Publicado: (2022)

Excellent clinical outcomes can be achieved with neoadjuvant chemoradiation and orthotopic liver transplantation for unresectable cholangiocarcinoma: support for the need of an international transplant protocol
por: Laughlin, Brady S., et al.
Publicado: (2022)

Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: Treatment technique and outcomes
por: Rao, Yuan James, et al.
Publicado: (2017)

Radiation Recall Dermatitis After the Use of Pralatrexate for Peripheral T-cell Lymphoma
por: Bhangoo, Ronik S., et al.
Publicado: (2018)

Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma
por: Deng, Wei, et al.
Publicado: (2020)

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy
por: Youssef, Fady F., et al.
Publicado: (2016)

Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus
por: Cardenas, Michael L., et al.
Publicado: (2017)

Dose-volume histogram parameters and patient-reported EPIC-Bowel domain in prostate cancer proton therapy
por: Bulman, Gabriella F., et al.
Publicado: (2021)

Proton beam radiotherapy for esophagus cancer: state of the art
por: Gergelis, Kimberly R., et al.
Publicado: (2020)

Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer
por: Bhangoo, Ronik S., et al.
Publicado: (2021)

Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC
por: Arnett, Andrea L.H., et al.
Publicado: (2019)

Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy
por: Lucido, J. John, et al.
Publicado: (2022)

Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003
por: Laughlin, Brady S., et al.
Publicado: (2022)

Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related adverse events, and patient-reported outcomes
por: Jethwa, Krishan R., et al.
Publicado: (2018)

Impact of COVID 19 Pandemic on Radiation Oncology Care Path Time
por: Laughlin, B., et al.
Publicado: (2022)

Angiosarcoma of the Seminal Vesicle: A Case Report of Long-Term Survival Following Multimodality Therapy
por: Chang, Kenneth, et al.
Publicado: (2014)

Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer
por: Jeans, Elizabeth B, et al.
Publicado: (2021)

Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery
por: Carpenter, David J., et al.
Publicado: (2022)

Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience
por: Yu, Nathan Y., et al.
Publicado: (2019)

Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience
por: Laughlin, Brady S., et al.
Publicado: (2023)

A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer
por: Routman, David M., et al.
Publicado: (2019)

Intensity Modulated Proton Therapy for Bilateral Breast or Chest Wall and Comprehensive Nodal Irradiation for Synchronous Bilateral Breast Cancer: Initial Clinical Experience and Dosimetric Comparison
por: Garda, Allison E., et al.
Publicado: (2022)

Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2023)

Evaluation of Operative Imaging Techniques in Surgical Education
por: Kothari, Shanu N., et al.
Publicado: (2004)

1622P The impact of COVID-19 on cancer treatment delivery in Sub-Saharan Africa
por: Merrell, K., et al.
Publicado: (2021)

Preoperative Upper Endoscopy is Useful Before Revisional Bariatric Surgery
por: Clapp, Benjamin, et al.
Publicado: (2007)

Outcome for Children with Metastatic Solid Tumors over the Last Four Decades
por: Perkins, Stephanie M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i5q29k6u356nc28jn3qajboo1v